NKX3-1 and prostate carcinoma: In prostate cancer, we observed that the lead variants are significantly enriched in NKX3-1 (n = 61 genes), followed by GATA2 (n = 13) (Fisher's exact test, P < 0.01 for all; Supplementary Data 8 and 10).